Close

Ratings by Citi (Neena Bitritto-Garg)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/5/2024 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
7/14/2023 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
6/23/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/24/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/15/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/12/2023 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
4/19/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
4/4/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
4/4/2023 Sarepta Therapeutics SRPT New Coverage Buy
(N/A)
137.83
(129.46)
-6.07% Details
3/14/2023 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
3/13/2023 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
3/1/2023 Alector Inc. ALEC Maintain Buy
(N/A)
 
 
  Details
3/1/2023 Compass Pathways CMPS Maintain Buy
(N/A)
 
 
  Details
2/24/2023 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
2/23/2023 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
2/16/2023 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
2/7/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/6/2023 atai Life Sciences N.V ATAI Maintain Buy
(N/A)
 
 
  Details
1/5/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
11/16/2022 Pear Therapeutics PEAR Maintain Buy
(N/A)
 
 
  Details
11/15/2022 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
11/11/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Passage Bio Inc. PASG Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Kodiak Sciences Inc. KOD Maintain Sell
(N/A)
 
 
  Details
11/10/2022 Decibel Therapeutics Inc DBTX Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Alector Inc. ALEC Maintain Buy
(N/A)
 
 
  Details
10/24/2022 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
10/24/2022 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
10/3/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
9/8/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
8/31/2022 atai Life Sciences N.V ATAI Maintain Buy
(N/A)
 
 
  Details
8/15/2022 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
8/12/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
8/12/2022 Pear Therapeutics PEAR Maintain Buy
(N/A)
 
 
  Details
8/11/2022 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
8/11/2022 Decibel Therapeutics Inc DBTX Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Kodiak Sciences Inc. KOD Maintain Sell
(N/A)
 
 
  Details
8/8/2022 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
15.62
(18.49)
18.37% Details
8/5/2022 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
15.62
(18.49)
18.37% Details
8/5/2022 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
8/4/2022 Compass Pathways CMPS Maintain Buy
(N/A)
 
 
  Details
8/2/2022 Kodiak Sciences Inc. KOD Downgrade Sell
(Neutral)
9.95
(5.26)
-47.14% Details
6/28/2022 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
6/21/2022 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
6/13/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
6/3/2022 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
6/1/2022 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
5/25/2022 Amylyx Pharmaceuticals inc. AMLX New Coverage Buy
(N/A)
8.42
(2.84)
-66.27% Details
5/17/2022 Decibel Therapeutics Inc DBTX Maintain Buy
(N/A)
 
 
  Details
5/17/2022 atai Life Sciences N.V ATAI Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Passage Bio Inc. PASG Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Pear Therapeutics PEAR Maintain Buy
(N/A)
 
 
  Details
5/16/2022 Prothena Corp PRTA Maintain Neutral
(N/A)
 
 
  Details
4/4/2022 Alpha Tau Medical Ltd. DRTS New Coverage Buy
(N/A)
10.54
(2.95)
-72.01% Details
3/29/2022 Pear Therapeutics PEAR Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Alector Inc. ALEC Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
1/26/2022 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
1/5/2022 Acadia Pharmaceuticals ACAD Upgrade Buy
(Neutral)
24.39
(18.49)
-24.19% Details
12/29/2021 Pear Therapeutics PEAR New Coverage Buy
(N/A)
5.09
(0.03)
-99.41% Details
12/21/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
12/8/2021 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
12/7/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
11/11/2021 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
11/11/2021 Decibel Therapeutics Inc DBTX Maintain Buy
(N/A)
 
 
  Details
11/11/2021 Cortexyme Inc. CRTX Maintain Sell
(N/A)
 
 
  Details
11/9/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
11/5/2021 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
11/2/2021 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
10/27/2021 Cortexyme Inc. CRTX Maintain Sell
(N/A)
 
 
  Details
9/27/2021 Cortexyme Inc. CRTX Maintain Sell
(N/A)
 
 
  Details
8/30/2021 Karuna Therapeutics Inc. KRTX New Coverage Buy
(N/A)
115.00
(329.83)
186.81% Details
8/10/2021 Longboard Pharmaceuticals Inc LBPH Maintain Buy
(N/A)
 
 
  Details
8/6/2021 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
7/13/2021 atai Life Sciences N.V ATAI New Coverage Buy
(N/A)
19.00
(1.97)
-89.63% Details
7/13/2021 Compass Pathways CMPS New Coverage Buy
(N/A)
36.65
(8.32)
-77.3% Details
7/5/2021 Alector Inc. ALEC Maintain Buy
(N/A)
 
 
  Details
6/16/2021 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
72.86
(18.74)
-74.28% Details
5/26/2021 Prothena Corp PRTA New Coverage Buy
(N/A)
25.05
(24.77)
-1.12% Details
5/7/2021 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
4/27/2021 Arena Pharma ARNA New Coverage Buy
(N/A)
68.75
(99.98)
45.43% Details
4/6/2021 Longboard Pharmaceuticals Inc LBPH New Coverage Buy
(N/A)
16.04
(20.18)
25.81% Details
4/5/2021 Acadia Pharma ACAD Maintain Neutral
(N/A)
 
 
  Details
3/9/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
45.78
(18.49)
-59.61% Details
3/9/2021 Decibel Therapeutics Inc DBTX New Coverage Buy
(N/A)
14.68
(4.91)
-66.55% Details
2/24/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
1/25/2021 Passage Bio Inc. PASG Upgrade Buy
(Neutral)
19.81
(1.35)
-93.19% Details
1/11/2021 Zogenix, Inc. ZGNX Maintain Neutral
(Neutral)
 
 
  Details
1/6/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/16/2020 Prevail Therapeutics PRVL Downgrade Neutral
(Buy)
12.50
(23.00)
84% Details
12/11/2020 Cortexyme Inc. CRTX New Coverage Sell
(N/A)
36.19
(1.95)
-94.61% Details
12/11/2020 Kodiak Sciences Inc. KOD New Coverage Neutral
(N/A)
124.11
(5.26)
-95.76% Details
12/11/2020 Passage Bio Inc. PASG New Coverage Neutral
(N/A)
27.72
(1.35)
-95.13% Details
12/1/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
11/11/2020 Alector Inc. ALEC Maintain Buy
(N/A)
 
 
  Details
11/10/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
7/21/2020 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
6/26/2020 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
6/26/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
4/8/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
3/19/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
3/19/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
3/6/2020 Zogenix, Inc. ZGNX New Coverage Neutral
(N/A)
27.36
(26.68)
-2.49% Details
3/6/2020 Sage Therapeutics SAGE New Coverage Buy
(N/A)
53.23
(18.74)
-64.79% Details
3/6/2020 Neurocrine Bio. NBIX New Coverage Buy
(N/A)
98.30
(137.92)
40.31% Details
3/6/2020 Alector Inc. ALEC New Coverage Buy
(N/A)
31.34
(6.02)
-80.79% Details
3/6/2020 Acadia Pharmaceuticals ACAD New Coverage Buy
(N/A)
44.53
(45.78)
2.81% Details
3/6/2020 GW Pharma GWPH New Coverage Buy
(N/A)
102.93
(218.96)
112.73% Details
3/5/2020 Prevail Therapeutics PRVL New Coverage Buy
(N/A)
16.55
(23.00)
38.97% Details